Orthofix Medical Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount
Orthofix Medical Inc. (OFIX) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount of $3.47 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2026-02-24
- Orthofix Medical Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2025 was $3.47M, a 73.41% increase from fiscal 2024.
- Orthofix Medical Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2024 was $2.00M, a 33.96% decline from fiscal 2023.
- Orthofix Medical Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2023 was $3.03M, a 334.72% increase from fiscal 2022.
- Orthofix Medical Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2022 was $697.00K, a 52.85% increase from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 12 month |
|---|---|
| 2025-12-31 | $3.47M 10-K · filed 2026-02-24 |
| 2024-12-31 | $2.00M 10-K · filed 2026-02-24 |
| 2023-12-31 | $3.03M 10-K · filed 2026-02-24 |
| 2022-12-31 | $697.00K 10-K · filed 2025-02-25 |
| 2021-12-31 | $456.00K 10-K · filed 2024-03-05 |
| 2020-12-31 | $375.00K 10-K · filed 2023-03-06 |
| 2019-12-31 | $1.50M 10-K · filed 2022-02-25 |
| 2018-12-31 | $606.00K 10-K · filed 2021-02-26 |
| 2017-12-31 | $123.00K 10-K · filed 2020-02-24 |
| 2016-12-31 | $2.15M 10-K · filed 2019-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |